Concepedia

Pascal Chanu

PC

17

Publications

441

Citations

13

H-Index

2008

Active since

Affiliations

Roche (Switzerland)(Current)

Roche (France)

Roche (United Kingdom)

Certara (United States)

Strategic Solutions Consulting (United States)

Pascal Chanu is an author at Roche (Switzerland) specializing in medicine, pharmacology, and pharmacotherapy.

ORCID

Top concepts

Publications per year

2008–2024

17

Publications

17

A Comprehensive Hepatitis C Viral Kinetic Model Explaining Cure

Eric Snoeck, Pascal Chanu, Marc Lavielle et al. · Clinical Pharmacology & Therapeutics · 2010 · 110 citations

Population Pharmacokinetics of Oseltamivir When Coadministered With Probenecid

Craig R. Rayner, Pascal Chanu, Ronald Gieschke et al. · The Journal of Clinical Pharmacology · 2008 · 51 citations

, , +12

Population pharmacokinetics, exposure-safety, and immunogenicity of atezolizumab in pediatric and young adult patients with cancer

Colby S. Shemesh, Pascal Chanu, Kris M. Jamsen et al. · Journal for ImmunoTherapy of Cancer · 2019 · 41 citations · Full text

Integrated Two‐Analyte Population Pharmacokinetic Model of Polatuzumab Vedotin in Patients With Non‐Hodgkin Lymphoma

Dan Lü, Tong Lu, Leonid Gibiansky et al. · CPT Pharmacometrics & Systems Pharmacology · 2019 · 34 citations · Full text

, , +19

Exposure-safety and exposure-efficacy analyses of polatuzumab vedotin in patients with relapsed or refractory diffuse large B-cell lymphoma

Tong Lu, Leonid Gibiansky, Xiaobin Li et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2020 · 24 citations · Full text

Rows per page

1–5 of 17